1 Osimertinib Market Overview 1.1 Osimertinib Product Overview 1.2 Osimertinib Market Segment by Type 1.2.1 40mg*30 Tablets 1.2.2 80mg*30 Tablets 1.2.3 40mg*10 Tablets 1.2.4 80mg*10 Tablets 1.3 Global Osimertinib Market Size by Type (2015-2026) 1.3.1 Global Osimertinib Market Size Overview by Type (2015-2026) 1.3.2 Global Osimertinib Historic Market Size Review by Type (2015-2020) 1.3.2.1 Global Osimertinib Sales Market Share Breakdown by Type (2015-2026) 1.3.2.2 Global Osimertinib Revenue Market Share Breakdown by Type (2015-2026) 1.3.2.3 Global Osimertinib Average Selling Price (ASP) by Type (2015-2026) 1.3.3 Global Osimertinib Market Size Forecast by Type (2021-2026) 1.3.3.1 Global Osimertinib Sales Market Share Breakdown by Application (2021-2026) 1.3.3.2 Global Osimertinib Revenue Market Share Breakdown by Application (2021-2026) 1.3.3.3 Global Osimertinib Average Selling Price (ASP) by Application (2021-2026) 1.4 Key Regions Market Size Segment by Type (2015-2020) 1.4.1 North America Osimertinib Sales Breakdown by Type (2015-2026) 1.4.2 Europe Osimertinib Sales Breakdown by Type (2015-2026) 1.4.3 Asia-Pacific Osimertinib Sales Breakdown by Type (2015-2026) 1.4.4 Latin America Osimertinib Sales Breakdown by Type (2015-2026) 1.4.5 Middle East and Africa Osimertinib Sales Breakdown by Type (2015-2026) 2 Global Osimertinib Market Competition by Company 2.1 Global Top Players by Osimertinib Sales (2015-2020) 2.2 Global Top Players by Osimertinib Revenue (2015-2020) 2.3 Global Top Players Osimertinib Average Selling Price (ASP) (2015-2020) 2.4 Global Top Manufacturers Osimertinib Manufacturing Base Distribution, Sales Area, Product Type 2.5 Osimertinib Market Competitive Situation and Trends 2.5.1 Osimertinib Market Concentration Rate (2015-2020) 2.5.2 Global 5 and 10 Largest Manufacturers by Osimertinib Sales and Revenue in 2019 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osimertinib as of 2019) 2.7 Date of Key Manufacturers Enter into Osimertinib Market 2.8 Key Manufacturers Osimertinib Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Global Osimertinib Status and Outlook by Region (2015-2026) 3.1 Global Osimertinib Market Size and CAGR by Region: 2015 VS 2020 VS 2026 3.2 Global Osimertinib Market Size Market Share by Region (2015-2020) 3.2.1 Global Osimertinib Sales Market Share by Region (2015-2020) 3.2.2 Global Osimertinib Revenue Market Share by Region (2015-2020) 3.2.3 Global Osimertinib Sales, Revenue, Price and Gross Margin (2015-2020) 3.3 Global Osimertinib Market Size Market Share by Region (2021-2026) 3.3.1 Global Osimertinib Sales Market Share by Region (2021-2026) 3.3.2 Global Osimertinib Revenue Market Share by Region (2021-2026) 3.3.3 Global Osimertinib Sales, Revenue, Price and Gross Margin (2021-2026) 3.4 North America Osimertinib Market Size YoY Growth (2015-2026) 3.4.1 North America Osimertinib Revenue YoY Growth (2015-2026) 3.4.2 North America Osimertinib Sales YoY Growth (2015-2026) 3.5 Asia-Pacific Osimertinib Market Size YoY Growth (2015-2026) 3.5.1 Asia-Pacific Osimertinib Revenue YoY Growth (2015-2026) 3.5.2 Asia-Pacific Osimertinib Sales YoY Growth (2015-2026) 3.6 Europe Osimertinib Market Size YoY Growth (2015-2026) 3.6.1 Europe Osimertinib Revenue YoY Growth (2015-2026) 3.6.2 Europe Osimertinib Sales YoY Growth (2015-2026) 3.7 Latin America Osimertinib Market Size YoY Growth (2015-2026) 3.7.1 Latin America Osimertinib Revenue YoY Growth (2015-2026) 3.7.2 Latin America Osimertinib Sales YoY Growth (2015-2026) 3.8 Middle East and Africa Osimertinib Market Size YoY Growth (2015-2026) 3.8.1 Middle East and Africa Osimertinib Revenue YoY Growth (2015-2026) 3.8.2 Middle East and Africa Osimertinib Sales YoY Growth (2015-2026) 4 Global Osimertinib by Application 4.1 Osimertinib Segment by Application 4.1.1 Locally Advanced NSCLC 4.1.2 Metastatic NSCLC 4.1.3 Other 4.2 Global Osimertinib Sales by Application: 2015 VS 2020 VS 2026 4.3 Global Osimertinib Historic Sales by Application (2015-2020) 4.4 Global Osimertinib Forecasted Sales by Application (2021-2026) 4.5 Key Regions Osimertinib Market Size by Application 4.5.1 North America Osimertinib by Application 4.5.2 Europe Osimertinib by Application 4.5.3 Asia-Pacific Osimertinib by Application 4.5.4 Latin America Osimertinib by Application 4.5.5 Middle East and Africa Osimertinib by Application 5 North America Osimertinib Market Size by Country (2015-2026) 5.1 North America Market Size Market Share by Country (2015-2020) 5.1.1 North America Osimertinib Sales Market Share by Country (2015-2020) 5.1.2 North America Osimertinib Revenue Market Share by Country (2015-2020) 5.2 North America Market Size Market Share by Country (2021-2026) 5.2.1 North America Osimertinib Sales Market Share by Country (2021-2026) 5.2.2 North America Osimertinib Revenue Market Share by Country (2021-2026) 5.3 North America Market Size YoY Growth by Country 5.3.1 U.S. Osimertinib Market Size YoY Growth (2015-2026) 5.3.2 Canada Osimertinib Market Size YoY Growth (2015-2026) 6 Europe Osimertinib Market Size by Country (2015-2026) 6.1 Europe Market Size Market Share by Country (2015-2020) 6.1.1 Europe Osimertinib Sales Market Share by Country (2015-2020) 6.1.2 Europe Osimertinib Revenue Market Share by Country (2015-2020) 6.2 Europe Market Size Market Share by Country (2021-2026) 6.2.1 Europe Osimertinib Sales Market Share by Country (2021-2026) 6.2.2 Europe Osimertinib Revenue Market Share by Country (2021-2026) 6.3 Europe Market Size YoY Growth by Country 6.3.1 Germany Osimertinib Market Size YoY Growth (2015-2026) 6.3.2 France Osimertinib Market Size YoY Growth (2015-2026) 6.3.3 U.K. Osimertinib Market Size YoY Growth (2015-2026) 6.3.4 Italy Osimertinib Market Size YoY Growth (2015-2026) 6.3.5 Russia Osimertinib Market Size YoY Growth (2015-2026) 7 Asia-Pacific Osimertinib Market Size by Country (2015-2026) 7.1 Asia-Pacific Market Size Market Share by Country (2015-2020) 7.1.1 Asia-Pacific Osimertinib Sales Market Share by Country (2015-2020) 7.1.2 Asia-Pacific Osimertinib Revenue Market Share by Country (2015-2020) 7.2 Asia-Pacific Market Size Market Share by Country (2021-2026) 7.2.1 Asia-Pacific Osimertinib Sales Market Share by Country (2021-2026) 7.2.2 Asia-Pacific Osimertinib Revenue Market Share by Country (2021-2026) 7.3 Asia-Pacific Market Size YoY Growth by Country 7.3.1 China Osimertinib Market Size YoY Growth (2015-2026) 7.3.2 Japan Osimertinib Market Size YoY Growth (2015-2026) 7.3.3 South Korea Osimertinib Market Size YoY Growth (2015-2026) 7.3.4 India Osimertinib Market Size YoY Growth (2015-2026) 7.3.5 Australia Osimertinib Market Size YoY Growth (2015-2026) 7.3.6 Taiwan Osimertinib Market Size YoY Growth (2015-2026) 7.3.7 Indonesia Osimertinib Market Size YoY Growth (2015-2026) 7.3.8 Thailand Osimertinib Market Size YoY Growth (2015-2026) 7.3.9 Malaysia Osimertinib Market Size YoY Growth (2015-2026) 7.3.10 Philippines Osimertinib Market Size YoY Growth (2015-2026) 7.3.11 Vietnam Osimertinib Market Size YoY Growth (2015-2026) 8 Latin America Osimertinib Market Size by Country (2015-2026) 8.1 Latin America Market Size Market Share by Country (2015-2020) 8.1.1 Latin America Osimertinib Sales Market Share by Country (2015-2020) 8.1.2 Latin America Osimertinib Revenue Market Share by Country (2015-2020) 8.2 Latin America Market Size Market Share by Country (2021-2026) 8.2.1 Latin America Osimertinib Sales Market Share by Country (2021-2026) 8.2.2 Latin America Osimertinib Revenue Market Share by Country (2021-2026) 8.3 Latin America Market Size YoY Growth by Country 8.3.1 Mexico Osimertinib Market Size YoY Growth (2015-2026) 8.3.2 Brazil Osimertinib Market Size YoY Growth (2015-2026) 8.3.3 Argentina Osimertinib Market Size YoY Growth (2015-2026) 9 Middle East and Africa Osimertinib Market Size by Country (2015-2026) 9.1 Middle East and Africa Market Size Market Share by Country (2015-2020) 9.1.1 Middle East and Africa Osimertinib Sales Market Share by Country (2015-2020) 9.1.2 Middle East and Africa Osimertinib Revenue Market Share by Country (2015-2020) 9.2 Middle East and Africa Market Size Market Share by Country (2021-2026) 9.2.1 Middle East and Africa Osimertinib Sales Market Share by Country (2021-2026) 9.2.2 Middle East and Africa Osimertinib Revenue Market Share by Country (2021-2026) 9.3 Middle East and Africa Market Size YoY Growth by Country 9.3.1 Turkey Osimertinib Market Size YoY Growth (2015-2026) 9.3.2 Saudi Arabia Osimertinib Market Size YoY Growth (2015-2026) 9.3.3 U.A.E Osimertinib Market Size YoY Growth (2015-2026) 10 Company Profiles and Key Figures in Osimertinib Business 10.1 AstraZeneca 10.1.1 AstraZeneca Corporation Information 10.1.2 AstraZeneca Description, Business Overview and Total Revenue 10.1.3 AstraZeneca Osimertinib Sales, Revenue and Gross Margin (2015-2020) 10.1.4 AstraZeneca Osimertinib Products Offered 10.1.5 AstraZeneca Recent Development 10.2 Incepta Pharmaceuticals Limited 10.2.1 Incepta Pharmaceuticals Limited Corporation Information 10.2.2 Incepta Pharmaceuticals Limited Description, Business Overview and Total Revenue 10.2.3 Incepta Pharmaceuticals Limited Osimertinib Sales, Revenue and Gross Margin (2015-2020) 10.2.4 AstraZeneca Osimertinib Products Offered 10.2.5 Incepta Pharmaceuticals Limited Recent Development 10.3 Everest Pharmaceuticals 10.3.1 Everest Pharmaceuticals Corporation Information 10.3.2 Everest Pharmaceuticals Description, Business Overview and Total Revenue 10.3.3 Everest Pharmaceuticals Osimertinib Sales, Revenue and Gross Margin (2015-2020) 10.3.4 Everest Pharmaceuticals Osimertinib Products Offered 10.3.5 Everest Pharmaceuticals Recent Development 10.4 Beacon Pharma 10.4.1 Beacon Pharma Corporation Information 10.4.2 Beacon Pharma Description, Business Overview and Total Revenue 10.4.3 Beacon Pharma Osimertinib Sales, Revenue and Gross Margin (2015-2020) 10.4.4 Beacon Pharma Osimertinib Products Offered 10.4.5 Beacon Pharma Recent Development 10.5 Drug International 10.5.1 Drug International Corporation Information 10.5.2 Drug International Description, Business Overview and Total Revenue 10.5.3 Drug International Osimertinib Sales, Revenue and Gross Margin (2015-2020) 10.5.4 Drug International Osimertinib Products Offered 10.5.5 Drug International Recent Development ... 11 Osimertinib Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Osimertinib Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Osimertinib Industrial Chain Analysis 11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Porter’s Five Forces Analysis 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Distributors 12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Author Details 14.4 Disclaimer

List of Tables Table 1. Major Company of 40mg*30 Tablets Table 2. Major Company of 80mg*30 Tablets Table 3. Major Players of 40mg*10 Tablets Table 4. Major Players of 80mg*10 Tablets Table 5. Global Osimertinib Market Size Growth Potential by Type: CAGR (2020-2026) (US$ Million) Table 6. Global Osimertinib Sales (K Pcs) by Type (2015-2020) (K Pcs) Table 7. Global Osimertinib Sales Share by Type (2015-2020) Table 8. Global Osimertinib Revenue (Million USD) by Type (2015-2020) Table 9. Global Osimertinib Revenue Share by Type (2015-2020) Table 10. Global Osimertinib Average Selling Price (ASP) (USD/Pcs) by Type (2015-2020) Table 11. Global Osimertinib Sales by Type (2021-2026) (K Pcs) Table 12. Global Osimertinib Sales Share by Type (2021-2026) Table 13. Global Osimertinib Revenue (US$ Million) by Type (2021-2026) Table 14. Global Osimertinib Revenue Share by Type (2021-2026) Table 15. Global Osimertinib Average Selling Price (ASP) (USD/Pcs) by Type (2021-2026) Table 16. North America Osimertinib Sales (USD/Pcs) by Type (2015-2020) Table 17. Europe Osimertinib Sales (USD/Pcs) by Type (2015-2020) Table 18. Asia-Pacific Osimertinib Sales (USD/Pcs) by Type (2015-2020) Table 19. Latin America Osimertinib Sales (USD/Pcs) by Type (2015-2020) Table 20. Middle East and Africa Osimertinib Sales (USD/Pcs) by Type (2015-2020) Table 21. Global Osimertinib Sales (K Pcs) by Company (2015-2020) Table 22. Global Osimertinib Sales Share by Company (2015-2020) Table 23. Global Osimertinib Revenue (Million US$) by Company (2015-2020) Table 24. Global Osimertinib Revenue Share by Company (2015-2020) Table 25. Global Market Osimertinib Average Selling Price (USD/Pcs) by Company (2015-2020) Table 26. Global Osimertinib Top Manufacturers Manufacturing Base Distribution and Sales Area Table 27. Global Osimertinib Top Manufacturers Product Category Table 28. Global Osimertinib Manufacturers Market Concentration Ratio (CR5 and HHI) Table 29. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osimertinib as of 2019 Table 30. Date of Key Manufacturers Enter into Osimertinib Market Table 31. Key Manufacturers Osimertinib Product Type Table 32. Mergers & Acquisitions, Expansion Plans Table 33. Global Osimertinib Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026 Table 34. Global Osimertinib Sales (K Pcs) by Region (2015-2020) Table 35. Global Osimertinib Sales Market Share by Region (2015-2020) Table 36. Global Osimertinib Revenue (US$ Million) by Region (2015-2020) Table 37. Global Osimertinib Revenue Market Share by Region (2015-2020) Table 38. Global Osimertinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 39. Global Osimertinib Sales (K Pcs) by Region (2021-2026) Table 40. Global Osimertinib Sales Market Share by Region (2021-2026) Table 41. Global Osimertinib Revenue (US$ Million) by Region (2021-2026) Table 42. Global Osimertinib Revenue Market Share by Region (2021-2026) Table 43. Global Osimertinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 44. Global Osimertinib Sales (K Pcs) by Application: 2015 VS 2020 VS 2026 Table 45. Global Osimertinib Sales (K Pcs) by Application (2015-2020) Table 46. Global Osimertinib Sales Share by Application (2015-2020) Table 47. Global Osimertinib Sales (K Pcs) by Application (2021-2026) Table 48. Global Osimertinib Sales Share by Application (2021-2026) Table 49. North America Osimertinib Sales (K Pcs) by Application (2015-2020) Table 50. North America Sales Osimertinib Market Share by Application (2015-2020) Table 51. Europe Osimertinib Sales (K Pcs) by Application (2015-2020) Table 52. Europe Sales Osimertinib Market Share by Application In 2019 Table 53. Asia-Pacific Osimertinib Sales (K Pcs) by Application (2015-2020) Table 54. Asia-Pacific Sales Osimertinib Market Share by Application In 2019 Table 55. Latin America Osimertinib Sales (K Pcs) by Application (2015-2020) Table 56. Latin America Sales Osimertinib Market Share by Application In 2019 Table 57. Middle East and Africa Osimertinib Sales (K Pcs) by Application (2015-2020) Table 58. Middle East and Africa Osimertinib Sales Share by Application (2015-2020) Table 59. North America Osimertinib Sales (K Pcs) by Country (2015-2020) Table 60. North America Osimertinib Sales Market Share by Country (2015-2020) Table 61. North America Osimertinib Revenue (US$ Million) by Country (2015-2020) Table 62. North America Osimertinib Revenue Market Share by Country (2015-2020) Table 63. North America Osimertinib Sales (K Pcs) by Country (2021-2026) Table 64. North America Osimertinib Sales Market Share by Country (2021-2026) Table 65. North America Osimertinib Revenue (US$ Million) by Country (2021-2026) Table 66. North America Osimertinib Revenue Market Share by Country (2021-2026) Table 67. Europe Osimertinib Sales (K Pcs) by Country (2015-2020) Table 68. Europe Osimertinib Sales Market Share by Country (2015-2020) Table 69. Europe Osimertinib Revenue (US$ Million) by Country (2015-2020) Table 70. Europe Osimertinib Revenue Market Share by Country (2015-2020) Table 71. Europe Osimertinib Sales (K Pcs) by Country (2021-2026) Table 72. Europe Osimertinib Sales Market Share by Country (2021-2026) Table 73. Europe Osimertinib Revenue (US$ Million) by Country (2021-2026) Table 74. Europe Osimertinib Revenue Market Share by Country (2021-2026) Table 75. Asia-Pacific Osimertinib Sales (K Pcs) by Region (2015-2020) Table 76. Asia-Pacific Osimertinib Sales Market Share by Region (2015-2020) Table 77. Asia-Pacific Osimertinib Revenue (US$ Million) by Region (2015-2020) Table 78. Asia-Pacific Osimertinib Revenue Market Share by Region (2015-2020) Table 79. Asia-Pacific Osimertinib Sales (K Pcs) by Region (2021-2026) Table 80. Asia-Pacific Osimertinib Sales Market Share by Region (2021-2026) Table 81. Asia-Pacific Osimertinib Revenue (US$ Million) by Region (2021-2026) Table 82. Asia-Pacific Osimertinib Revenue Market Share by Region (2021-2026) Table 83. Latin America Osimertinib Sales (K Pcs) by Country (2015-2020) Table 84. Latin America Osimertinib Sales Market Share by Country (2015-2020) Table 85. Latin America Osimertinib Revenue (US$ Million) by Country (2015-2020) Table 86. Latin America Osimertinib Revenue Market Share by Country (2015-2020) Table 87. Latin America Osimertinib Sales (K Pcs) by Country (2021-2026) Table 88. Latin America Osimertinib Sales Market Share by Country (2021-2026) Table 89. Latin America Osimertinib Revenue (US$ Million) by Country (2021-2026) Table 90. Latin America Osimertinib Revenue Market Share by Country (2021-2026) Table 91. Middle East and Africa Osimertinib Sales (K Pcs) by Country (2015-2020) Table 92. Middle East and Africa Osimertinib Sales Market Share by Country (2015-2020) Table 93. Middle East and Africa Osimertinib Revenue (US$ Million) by Country (2015-2020) Table 94. Middle East and Africa Osimertinib Revenue Market Share by Country (2015-2020) Table 95. Middle East and Africa Osimertinib Sales (K Pcs) by Country (2021-2026) Table 96. Middle East and Africa Osimertinib Sales Market Share by Country (2021-2026) Table 97. Middle East and Africa Osimertinib Revenue (US$ Million) by Country (2021-2026) Table 98. Middle East and Africa Osimertinib Revenue Market Share by Country (2021-2026) Table 99. AstraZeneca Corporation Information Table 100. AstraZeneca Description and Business Overview Table 101. AstraZeneca Osimertinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 102. AstraZeneca Osimertinib Product Table 103. AstraZeneca Recent Development Table 104. Incepta Pharmaceuticals Limited Corporation Information Table 105. Incepta Pharmaceuticals Limited Description and Business Overview Table 106. Incepta Pharmaceuticals Limited Osimertinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 107. Incepta Pharmaceuticals Limited Osimertinib Product Table 108. Incepta Pharmaceuticals Limited Recent Development Table 109. Everest Pharmaceuticals Corporation Information Table 110. Everest Pharmaceuticals Description and Business Overview Table 111. Everest Pharmaceuticals Osimertinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 112. Everest Pharmaceuticals Osimertinib Product Table 113. Everest Pharmaceuticals Recent Development Table 114. Beacon Pharma Corporation Information Table 115. Beacon Pharma Description and Business Overview Table 116. Beacon Pharma Osimertinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 117. Beacon Pharma Osimertinib Product Table 118. Beacon Pharma Recent Development Table 119. Drug International Corporation Information Table 120. Drug International Description and Business Overview Table 121. Drug International Osimertinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 122. Drug International Osimertinib Product Table 123. Drug International Recent Development Table 124. Key Raw Materials Lists Table 125. Raw Materials Key Suppliers Lists Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 127. Key Challenges Table 128. Market Risks Table 129. Distributors List Table 130. Osimertinib Downstream Customers Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Osimertinib Product Picture Figure 2. Global Osimertinib Revenue (Million USD) Status and Outlook (2015-2026) Figure 3. Global Osimertinib Sales (K Pcs) Status and Outlook (2015-2026) Figure 4. Product Picture of 40mg*30 Tablets Figure 5. Global 40mg*30 Tablets Sales (K Pcs) and Growth Rate (2015-2020) Figure 6. Product Picture of 80mg*30 Tablets Figure 7. Global 80mg*30 Tablets Sales (K Pcs) and Growth Rate (2015-2020) Figure 8. Product Picture of 40mg*10 Tablets Figure 9. Global 40mg*10 Tablets Sales (K Pcs) and Growth Rate (2015-2020) Figure 10. Product Picture of 80mg*10 Tablets Figure 11. Global 80mg*10 Tablets Sales (K Pcs) and Growth Rate (2015-2020) Figure 12. Global Osimertinib Revenue and Growth Rate by Type (US$ Million) Figure 13. Global Osimertinib Sales Market Share by Type (2015-2020) Figure 14. Global Osimertinib Sales Market Share by Type in 2019 Figure 15. Global Osimertinib Revenue Share by Type (2015-2020) Figure 16. Global Osimertinib Revenue Market Share by Type in 2019 Figure 17. Global Osimertinib Sales Market Share by Type (2021-2026) Figure 18. Global Osimertinib Sales Market Share by Type In 2019 Figure 19. Global Osimertinib Revenue Share by Type (2021-2026) Figure 20. Global Osimertinib Revenue Market Share by Type In 2019 Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Osimertinib Sales in 2019 Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Osimertinib Revenue in 2019 Figure 23. Osimertinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 24. North America Osimertinib Revenue (US$ Million) and Growth Rate (2015-2026) Figure 25. North America Osimertinib Sales YoY Growth (2015-2026) (K Pcs) Figure 26. Asia-Pacific Osimertinib Revenue (US$ Million) and Growth Rate (2015-2026) Figure 27. Asia-Pacific Osimertinib Sales YoY Growth (2015-2026) (K Pcs) Figure 28. Europe Osimertinib Revenue (US$ Million) and Growth Rate (2015-2026) Figure 29. Europe Osimertinib Sales YoY Growth (2015-2026) (K Pcs) Figure 30. Latin America Osimertinib Revenue (US$ Million) and Growth Rate (2015-2026) Figure 31. Latin America Osimertinib Sales YoY Growth (2015-2026) (K Pcs) Figure 32. Middle East and Africa Osimertinib Revenue (US$ Million) and Growth Rate (2015-2026) Figure 33. Middle East and Africa Osimertinib Sales YoY Growth (2015-2026) (K Pcs) Figure 34. Locally Advanced NSCLC Examples Figure 35. Metastatic NSCLC Examples Figure 36. Other Examples Figure 37. U.S. Osimertinib Sales (K Pcs) (2015-2026) Figure 38. U.S. Osimertinib Revenue (US$ Million) (2015-2026) Figure 39. Canada Osimertinib Sales (K Pcs) (2015-2026) Figure 40. Canada Osimertinib Revenue (US$ Million) (2015-2026) Figure 41. Germany Osimertinib Sales (K Pcs) (2015-2026) Figure 42. Germany Osimertinib Revenue (US$ Million) (2015-2026) Figure 43. France Osimertinib Sales (K Pcs) (2015-2026) Figure 44. France Osimertinib Revenue (US$ Million) (2015-2026) Figure 45. U.K. Osimertinib Sales (K Pcs) (2015-2026) Figure 46. U.K. Osimertinib Revenue (US$ Million) (2015-2026) Figure 47. Italy Osimertinib Sales (K Pcs) (2015-2026) Figure 48. Italy Osimertinib Revenue (US$ Million) (2015-2026) Figure 49. Russia Osimertinib Sales (K Pcs) (2015-2026) Figure 50. Russia Osimertinib Revenue (US$ Million) (2015-2026) Figure 51. China Osimertinib Sales (K Pcs) (2015-2026) Figure 52. China Osimertinib Revenue (US$ Million) (2015-2026) Figure 53. Japan Osimertinib Sales (K Pcs) (2015-2026) Figure 54. Japan Osimertinib Revenue (US$ Million) (2015-2026) Figure 55. South Korea Osimertinib Sales (K Pcs) (2015-2026) Figure 56. South Korea Osimertinib Revenue (US$ Million) (2015-2026) Figure 57. India Osimertinib Sales (K Pcs) (2015-2026) Figure 58. India Osimertinib Revenue (US$ Million) (2015-2026) Figure 59. Australia Osimertinib Sales (K Pcs) (2015-2026) Figure 60. Australia Osimertinib Revenue (US$ Million) (2015-2026) Figure 61. Taiwan Osimertinib Sales (K Pcs) (2015-2026) Figure 62. Taiwan Osimertinib Revenue (US$ Million) (2015-2026) Figure 63. Indonesia Osimertinib Sales (K Pcs) (2015-2026) Figure 64. Indonesia Osimertinib Revenue (US$ Million) (2015-2026) Figure 65. Thailand Osimertinib Sales (K Pcs) (2015-2026) Figure 66. Thailand Osimertinib Revenue (US$ Million) (2015-2026) Figure 67. Malaysia Osimertinib Sales (K Pcs) (2015-2026) Figure 68. Malaysia Osimertinib Revenue (US$ Million) (2015-2026) Figure 69. Philippines Osimertinib Sales (K Pcs) (2015-2026) Figure 70. Philippines Osimertinib Revenue (US$ Million) (2015-2026) Figure 71. Vietnam Osimertinib Sales (K Pcs) (2015-2026) Figure 72. Vietnam Osimertinib Revenue (US$ Million) (2015-2026) Figure 73. Mexico Osimertinib Sales (K Pcs) (2015-2026) Figure 74. Mexico Osimertinib Revenue (US$ Million) (2015-2026) Figure 75. Brazil Osimertinib Sales (K Pcs) (2015-2026) Figure 76. Brazil Osimertinib Revenue (US$ Million) (2015-2026) Figure 77. Argentina Osimertinib Sales (K Pcs) (2015-2026) Figure 78. Argentina Osimertinib Revenue (US$ Million) (2015-2026) Figure 79. Turkey Osimertinib Sales (K Pcs) (2015-2026) Figure 80. Turkey Osimertinib Revenue (US$ Million) (2015-2026) Figure 81. Saudi Arabia Osimertinib Sales (K Pcs) (2015-2026) Figure 82. Saudi Arabia Osimertinib Revenue (US$ Million) (2015-2026) Figure 83. U.A.E Osimertinib Sales (K Pcs) (2015-2026) Figure 84. U.A.E Osimertinib Revenue (US$ Million) (2015-2026) Figure 85. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 86. Incepta Pharmaceuticals Limited Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Everest Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Beacon Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Drug International Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Key Raw Materials Price Figure 91. Osimertinib Manufacturing Cost Structure Figure 92. Osimertinib Industrial Chain Analysis Figure 93. Porter's Five Forces Analysis Figure 94. Channels of Distribution Figure 95. Distributors Profiles Figure 96. Bottom-up and Top-down Approaches for This Report Figure 97. Data Triangulation Figure 98. Key Executives Interviewed

AstraZeneca Incepta Pharmaceuticals Limited Everest Pharmaceuticals Beacon Pharma Drug International